These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12877612)

  • 1. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up.
    Schillinger M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Minar E
    J Endovasc Ther; 2003 Apr; 10(2):288-97. PubMed ID: 12877612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
    J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
    Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for subclavian artery angioplasty: is there an increased rate of restenosis after stent implantation?
    Schillinger M; Haumer M; Schillinger S; Ahmadi R; Minar E
    J Endovasc Ther; 2001 Dec; 8(6):550-7. PubMed ID: 11797967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
    Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
    J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: an alternative in patients with renal insufficiency.
    Ascher E; Marks NA; Schutzer RW; Hingorani AP
    J Vasc Surg; 2005 Dec; 42(6):1108-13. PubMed ID: 16376200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial.
    Amighi J; Schillinger M; Dick P; Schlager O; Sabeti S; Mlekusch W; Haumer M; Mathies R; Heinzle G; Schuster A; Loewe C; Koppensteiner R; Lammer J; Minar E; Cejna M
    Radiology; 2008 Apr; 247(1):267-72. PubMed ID: 18270378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
    Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
    J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)].
    Grenacher L; Saam T; Geier A; Müller-Hülsbeck S; Cejna M; Kauffmann GW; Richter GM
    Rofo; 2004 Sep; 176(9):1302-10. PubMed ID: 15346266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
    Schillinger M; Haumer M; Schlerka G; Mlekusch W; Exner M; Ahmadi R; Minar E
    J Endovasc Ther; 2001 Oct; 8(5):477-83. PubMed ID: 11718406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty : results of a prospective randomized study.
    Minar E; Pokrajac B; Maca T; Ahmadi R; Fellner C; Mittlböck M; Seitz W; Wolfram R; Pötter R
    Circulation; 2000 Nov; 102(22):2694-9. PubMed ID: 11094034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
    Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.